134 terminated. 134 Phase 2, 32 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 134 | Terminated 134 |
| Phase 1 | 32 | Terminated 32 |
Follow Brain Neoplasms: new trials by email Literature Review of Brain Neoplasms trials Research Report on Brain Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases Tiragolumab, Atezolizumab, Pemetrexed - Non-small Cell Lung Cancer | Phase 2 | Terminated | Liza Villaruz, MD | 3 | 2023-08-10 | 2026-01-22 |
| Oral AMXT 1501 Dicaprate in Combination With IV DFMO AMXT1501, DFMO - Cancer, Solid Tumor | Phase 1 / Phase 2 | Terminated | Aminex Therapeutics, Inc. | 15 | 2022-11-29 | 2024-12-24 |
| Pembro+Chemo in Brain Mets Pembrolizumab, Nab paclitaxel, Paclitaxel - Lung Cancer, Lung Cancer Metastatic | Phase 2 | Terminated | John L. Villano, MD, PhD | 3 | 2022-05-19 | 2025-10-31 |
| Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma Pembrolizumab, Lenvatinib - Melanoma, Renal Cell Carcinoma | Phase 2 | Terminated | Yale University | 18 | 2022-02-09 | 2026-06-04 |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Alectinib - Neoplasms, Colorectal Neoplasms | Phase 2 | Terminated | Hoffmann-La Roche | 1 | 2021-05-24 | 2023-08-07 |
| Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases Glucocorticoid therapy - Brain Metastases, Adult | Phase 2 | Terminated | AHS Cancer Control Alberta | 2 | 2021-03-30 | 2025-06-27 |
| Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases Bintrafusp Alfa, Pimasertib, Quality-of-Life Assessment - Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 8 | 2021-01-15 | 2026-03-18 |
| Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases Carboplatin, Etoposide, Atezolizumab - Small-cell Lung Cancer, Brain Metastases | Phase 2 | Terminated | Jeffrey Clarke | 3 | 2021-01-05 | 2024-03-13 |
| Brigatinib Before Brain Irradiation Trial (B3i Trial) Brigatinib - Brain Metastases, Lung Cancer | Phase 2 | Terminated | University of Colorado, Denver | 1 | 2020-11-17 | 2022-10-24 |
| Neoadjuvant Immunotherapy in Brain Metastases Nivolumab, Ipilimumab - Brain Metastases, Adult | Phase 2 | Terminated | Sarah Sammons, MD | 1 | 2020-11-04 | 2022-07-26 |
| Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases AGuIX - Brain Metastases | Phase 2 | Terminated | Centre Leon Berard | 1 | 2020-01-17 | 2021-06-08 |
| Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas Capecitabine, Temozolomide - Recurrent Pituitary Adenomas | Phase 2 | Terminated | Weill Medical College of Cornell University | 1 | 2019-05-21 | 2022-08-09 |
| Focal Intraoperative Radiotherapy of Brain Metastases Intraoperative Radiotherapy - Brain Metastases, Adult, Central Nervous System Metastases | Phase 2 | Terminated | AC Camargo Cancer Center | 10 | 2019-05-02 | 2023-07-27 |
| An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis encorafenib, binimetinib - Brain Metastases | Phase 2 | Terminated | Pfizer | 13 | 2019-04-30 | 2023-05-31 |
| Sunitinib in Sarcomas of the Central Nervous System Sunitinib, wGT3x-BT - Gliosarcoma, Central Nervous System Sarcoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2019-02-21 | 2022-04-19 |
| Seizure Prophylaxis in Patients With Glioma or Brain Metastasis Lacosamide, Levetiracetam - Glioma, Glioma of Brain | Phase 2 | Terminated | Duke University | 4 | 2019-01-31 | 2023-04-13 |
| A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT Panobinostat - Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor | Phase 2 | Terminated | Australian & New Zealand Children's Haematology/Oncology Group | 25 | 2019-01-09 | 2025-02-24 |
| REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma cemiplimab (monotherapy), cemiplimab (maintenance), Conventional or hypofractionated - Relapsed Solid Tumor, Refractory Solid Tumor | Phase 1 / Phase 2 | Terminated | Regeneron Pharmaceuticals | 57 | 2018-09-24 | 2025-04-08 |
| [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors [18F]FLT, [18F]Fluciclovine - Brain Tumor | Phase 1 / Phase 2 | Terminated | University of Utah | 10 | 2018-09-24 | 2024-12-27 |
| Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases Vemurafenib, Cobimetinib - Malignant Melanoma Stage IV, BRAF V600 Mutation | Phase 2 | Terminated | Technische Universität Dresden | 20 | 2018-07-01 | 2023-09-14 |
Showing 20 of 134. Sign in to see all of them.
Glioblastoma (41) · Glioma (28) · Astrocytoma (19) · Gliosarcoma (18) · Melanoma (17) · Neoplasm Metastasis (16) · Breast Neoplasms (14) · Carcinoma, Non-Small-Cell Lung (14) · Central Nervous System Neoplasms (11) · Lung Neoplasms (9) · Oligodendroglioma (9) · Diffuse Intrinsic Pontine Glioma (8) · Neoplasms (7) · Pituitary Neoplasms (7)
Brain Diseases (134) · Nervous System Diseases (134) · Nervous System Neoplasms (134) · Central Nervous System Diseases (133) · Neoplasms by Site (133) · Neoplasms (127) · Central Nervous System Neoplasms (123) · Neoplasms by Histologic Type (80) · Neoplasms, Nerve Tissue (76) · Neuroectodermal Tumors (76) · Neoplasms, Germ Cell and Embryonal (74) · Neoplasms, Glandular and Epithelial (64) · Neoplasms, Neuroepithelial (59) · Glioma (30) · Pathological Conditions, Signs and Symptoms (27)
Temozolomide (21) · Bevacizumab (10) · Radiotherapy (7) · Capecitabine (5) · Carboplatin (4) · Erlotinib Hydrochloride (4) · Nivolumab (4) · Radiation (4) · Radiosurgery (4) · Sunitinib (4) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (3) · Ipilimumab (3) · Mental Status and Dementia Tests (3) · Pemetrexed (3) · Topotecan (3)
National Cancer Institute (NCI) (12) · M.D. Anderson Cancer Center (5) · Duke University (4) · Novartis Pharmaceuticals (4) · Alliance for Clinical Trials in Oncology (3) · AHS Cancer Control Alberta (2) · Case Comprehensive Cancer Center (2) · Children's Hospital Medical Center, Cincinnati (2) · GlaxoSmithKline (2) · H. Lee Moffitt Cancer Center and Research Institute (2) · Liza Villaruz, MD (2) · Merck Sharp & Dohme LLC (2) · Methodist Healthcare - Memphis (2) · OHSU Knight Cancer Institute (2) · University College, London (2)
United States (105) · Canada (13) · Germany (8) · Italy (7) · Spain (7) · Australia (6) · Belgium (6) · France (5) · Netherlands (5) · Brazil (4) · United Kingdom (4) · Argentina (3) · Mexico (3) · Greece (2) · Switzerland (2)
Allen K Sills, MD (2) · Edward Pan, MD (2) · Hamidreza Aliabadi, MD (2) · Howard A Fine, M.D. (2) · James E. Herndon, PhD (2) · John H. Sampson, MD, PhD (2) · John P. Kirkpatrick, MD (2) · Adrienne C Scheck, PhD (1) · Annick Desjardins, M.D. (1) · Anthony Brade, M.D. (1) · Anthony Heaney, MD (1) · Arjun Sahgal (1) · Ashley Sumrall, MD (1)
PMID 12749708, PMID 16648043, PMID 20042969, PMID 21865400, PMID 22198309, PMID 27232884, PMID 29741745, PMID 31401903, PMID 31776899, PMID 32270710, PMID 32354716, PMID 32603316, PMID 33034839, PMID 34359048, PMID 34540703, PMID 36705597, PMID 37876540, PMID 40721826
2009 (3), 2015 (2), U01CA137443 (2), 2008 (1), 2016 (1), 2017 (1), 2018 (1), N01CM00039 (1), P30CA014236 (1), P30CA016672 (1), P30CA033572 (1), P30CA043703 (1), P30CA046934 (1), P30CA124435 (1), P50NS020023 (1)